SCHEMBL7501153

SCHEMBL7501153

CCOC(=O)Cc1nc(-c2ccccc2)c(-c2ccc(S(C)(=O)=O)cc2)o1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 7/20 0.60
NR4A2 P43354 8/20 0.56
NR4A1 P22736 3/20 0.55
NR4A3 Q92570 3/20 0.55
RXRA P19793 4/20 0.50
RXRB P28702 3/20 0.50
KDM4E B2RXH2 2/20 0.50
HPGD P15428 2/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
ALDH1A1 P00352 1/20 0.50
KMT2A Q03164 1/20 0.48
PTGS1 P23219 2/20 0.47
ABCC4 O15439 1/20 0.47
C5 P01031 1/20 0.47
LMNA P02545 1/20 0.47
CHRM2 P08172 1/20 0.47
CYP3A4 P08684 1/20 0.47
CHRM1 P11229 1/20 0.47
DRD2 P14416 1/20 0.47
TSHR P16473 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7503163 1.00 PTGS2 (0.60) PTGS2NR4A2NR4A1NR4A3RXRA
SCHEMBL7501262 0.90 NR4A2 (0.55) PTGS2NR4A2NR4A1NR4A3RXRA
SCHEMBL7499580 0.90 NR4A2 (0.55) PTGS2NR4A2NR4A1NR4A3RXRA
SCHEMBL7500076 0.90 PTGS2 (0.61) PTGS2NR4A2PTGS1
SCHEMBL8557768 0.90 NR4A2 (0.68) PTGS2NR4A2NR4A1NR4A3RXRA
SCHEMBL7506899 0.89 KDM4E (0.63) PTGS2NR4A2NR4A1NR4A3RXRA
SCHEMBL7510918 0.89 KDM4E (0.63) PTGS2NR4A2NR4A1NR4A3RXRA
SCHEMBL7501454 0.89 PTGS2 (0.59) PTGS2NR4A2NR4A1NR4A3RXRA
SCHEMBL7503550 0.89 PTGS2 (0.59) PTGS2NR4A2NR4A1NR4A3RXRA
SCHEMBL7502488 0.88 RXRA (0.58) PTGS2NR4A2NR4A1NR4A3RXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0699192-B1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-07-24 EP claimed
EP-0699192-A1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-03-06 EP claimed
WO-1994027980-A1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1994-12-08 WO claimed
EP-0699192-B1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-07-24 EP disclosed
US-5719163-A ARTHRITIS G.D. SEARLE & CO. (US) 1998-02-17 US disclosed